Christopher P. Evans
YOU?
Author Swipe
View article: Supplementary Figure 4. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
Supplementary Figure 4. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer Open
Gene Ontology (GO) with Biological processes (BP) on the genes uniquely up- or down-regulated within each subtype
View article: Supplementary Figure 6. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
Supplementary Figure 6. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer Open
Gene expression level of CHD7 among the mCRPC tumors of Beltran et al. cohort
View article: Supplementary Figure 3. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
Supplementary Figure 3. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer Open
Volcano plots representing the differentially expressed (DE) genes in the mCRPC subtypes compared to AR+/NE- tumors
View article: Supplementary Table 1. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
Supplementary Table 1. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer Open
Clinical characteristics of samples in WCDT cohort
View article: Supplementary Table 3. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
Supplementary Table 3. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer Open
ETS family fusions detected in the WCDT samples
View article: Supplementary Figure 7. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
Supplementary Figure 7. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer Open
A heatmap representing the enrichment of transcription factors (TF) in hypermethylated regions of different subtypes of the WCDT samples
View article: Supplementary Figure 5. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
Supplementary Figure 5. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer Open
Gene expression level of SOX2 among the tumor subtypes of WCDT samples
View article: Supplementary Table 2. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
Supplementary Table 2. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer Open
Molecular Charactersistcs of samples in WCDT cohort
View article: Supplementary Figure 4. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer
Supplementary Figure 4. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer Open
Gene Ontology (GO) with Biological processes (BP) on the genes uniquely up- or down-regulated within each subtype
View article: Supplementary Figure 3. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer
Supplementary Figure 3. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer Open
Volcano plots representing the differentially expressed (DE) genes in the mCRPC subtypes compared to AR+/NE- tumors
View article: Supplementary Data 1. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer
Supplementary Data 1. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer Open
List of Differentially expressed genes in the subtypes of mCRPC in comparison with AR+/NE- tumors
View article: Supplementary Figure 2. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer
Supplementary Figure 2. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer Open
Hierarchical clustering analyses of benign, localized, and mCRPC tumors representing the expression of neuroendocrine marker genes (NE), androgen-related genes (AR), and genes related to squamous (SQUAM) differentiation
View article: Supplementary Data 2. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer
Supplementary Data 2. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer Open
List of enriched motifs identified in the hyper- and hypo-methylated regions of mCRPC subtypes
View article: Supplementary Figure 6. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer
Supplementary Figure 6. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer Open
Gene expression level of CHD7 among the mCRPC tumors of Beltran et al. cohort
View article: Supplementary Figure 8. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer
Supplementary Figure 8. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer Open
Gene expression level of Krüppel-like factor (KLF) family among the five mCRPC subtypes
View article: Supplementary Figure 3. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer
Supplementary Figure 3. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer Open
Volcano plots representing the differentially expressed (DE) genes in the mCRPC subtypes compared to AR+/NE- tumors
View article: Supplementary Table 3. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer
Supplementary Table 3. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer Open
ETS family fusions detected in the WCDT samples
View article: Supplementary Table 1. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer
Supplementary Table 1. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer Open
Clinical characteristics of samples in WCDT cohort
View article: Supplementary Figure 6. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer
Supplementary Figure 6. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer Open
Gene expression level of CHD7 among the mCRPC tumors of Beltran et al. cohort
View article: Supplementary Figure 1. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer
Supplementary Figure 1. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer Open
Hierarchical clustering and principal component analyses (PCA) on the mCRPC tumors of WCDT cohort.
View article: Supplementary Figure 7. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer
Supplementary Figure 7. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer Open
A heatmap representing the enrichment of transcription factors (TF) in hypermethylated regions of different subtypes of the WCDT samples
View article: Supplementary Figure 5. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer
Supplementary Figure 5. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer Open
Gene expression level of SOX2 among the tumor subtypes of WCDT samples
View article: Supplementary Table 3. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer
Supplementary Table 3. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer Open
ETS family fusions detected in the WCDT samples
View article: Supplementary Figure 1. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer
Supplementary Figure 1. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer Open
Hierarchical clustering and principal component analyses (PCA) on the mCRPC tumors of WCDT cohort.
View article: Supplementary Figure 8. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer
Supplementary Figure 8. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer Open
Gene expression level of Krüppel-like factor (KLF) family among the five mCRPC subtypes
View article: Supplementary Table 2. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer
Supplementary Table 2. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer Open
Molecular Charactersistcs of samples in WCDT cohort
View article: Supplementary Data 1. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer
Supplementary Data 1. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer Open
List of Differentially expressed genes in the subtypes of mCRPC in comparison with AR+/NE- tumors
View article: Supplementary Figure 5. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer
Supplementary Figure 5. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer Open
Gene expression level of SOX2 among the tumor subtypes of WCDT samples
View article: Supplementary Table 2. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer
Supplementary Table 2. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer Open
Molecular Charactersistcs of samples in WCDT cohort
View article: Supplementary Figure 7. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer
Supplementary Figure 7. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer Open
A heatmap representing the enrichment of transcription factors (TF) in hypermethylated regions of different subtypes of the WCDT samples